The latest in idea hub news.
The School of Public Health has launched a new Center for Health Data Science to advance scholarship in one of the most dynamic and promising areas of public health research.…
Identifying genetic variants and the role they play in predisposing people to Alzheimer’s disease can help researchers better understand how to treat the neurodegenerative condition for which there is currently…
Clinical knowledge about chronic traumatic encephalopathy (CTE) has come a long way, but there is still much to learn about this neurodegenerative disorder caused by repeated head injuries over time.…
School of Public Health student Megan Ryder earned first place in the 2024 BU Climate Innovation Challenge for her proposal for a community-driven tree planting initiative designed to curb Boston’s urban heat island…
A new study led by School of Public Health researchers reveals that the now-expired 2021 CTC expansion benefitted families experiencing financial setbacks due to health or employment challenges spurred by…
Glucagon-like peptide-1 (GLP-1) receptor agonists, a new class of drugs sold under names such as Ozempic, Wegovy, and Zepbound, are soaring in popularity for their ability to achieve and sustain substantial weight loss and improve cardiometabolic health.…